Substrate-directed control of N-glycosylation in the endoplasmic reticulum calibrates signal reception at the cell-surface
Preprint
Abstract
One-fifth of human proteins are N-glycosylated in the endoplasmic reticulum (ER) by two oligosaccharyltransferases, OST-A and OST-B. Contrary to the prevailing view of N-glycosylation as a housekeeping function, we identified an ER pathway that modulates the activity of OST-A. Genetic analyses linked OST-A to HSP90B1, an ER chaperone for membrane receptors, and CCCD134, an ER protein we identify as the first specificity factor for N-glycosylation. During its translocation into the ER, a N-terminal peptide in HSP90B1 functions as a pseudosubstrate inhibitor of OST-A and templates the assembly of specialized ER translocon complexes containing CCDC134. Unexpectedly, OST-A functions as a scaffold rather than an enzyme in this context, stabilizing HSP90B1 by preventing its hyperglycosylation and degradation. Disruption of this pathway impairs WNT signaling at the cell surface and causes the bone developmental disorder Osteogenesis Imperfecta. Thus, N-glycosylation can be regulated by ER factors to control cell-surface receptor signaling and tissue development. One-Sentence Summary N-glycosylation of asparagine residues on proteins can be regulated by specificity factors in the endoplasmic reticulum to control cell-surface signaling and tissue development.Keywords
This publication has 81 references indexed in Scilit:
- The recurrent homozygous translation start site variant in CCDC134 in an individual with severe osteogenesis imperfecta of non‐Morrocan ancestryAmerican Journal of Medical Genetics Part A, 2022
- Enrichment of Intact Glycopeptides Using Strong Anion Exchange and Electrostatic Repulsion Hydrophilic Interaction Chromatography2021
- Homozygous Loss-of-Function Mutations in CCDC134 Are Responsible for a Severe Form of Osteogenesis ImperfectaJournal of Bone and Mineral Research, 2020
- N-glycoprotein macroheterogeneity: biological implications and proteomic characterizationGlycoconjugate Journal, 2015
- WNT1 Mutations in Families Affected by Moderately Severe and Progressive Recessive Osteogenesis ImperfectaThe American Journal of Human Genetics, 2013
- CCDC134 interacts with hADA2a and functions as a regulator of hADA2a in acetyltransferase activity, DNA damage-induced apoptosis and cell cycle arrestHistochemistry and Cell Biology, 2012
- Endoglycosidase and Glycoamidase Release of N‐Linked GlycansCurrent Protocols in Protein Science, 2010
- In Vitro Dissection of Protein Translocation into the Mammalian Endoplasmic Reticulum2010
- CCDC134, a novel secretory protein, inhibits activation of ERK and JNK, but not p38 MAPKCellular and Molecular Life Sciences, 2007
- [4] Enzymatic deglycosylation of asparagine-linked glycans: Purification, properties, and specificity of oligosaccharide-cleaving enzymes from Flavobacterium meningosepticum1994